References
- Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376–387.
- Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160–167.
- Eaton CB, Roberts M, Driban JB, et al. Multiple joint osteoarthritis in the osteoarthritis initiative. Osteoarthr Cartil. 2019;27:S100.
- Gu YT, Chen J, Meng ZL, et al. Research progress on osteoarthritis treatment mechanisms. Biomed Pharmacother. 2017;93:1246–1252.
- Banks C, Hughes K, Simpkins C, et al. Osteoarthritis in older adults: nonsteroidal anti-inflammatory drugs versus opioids. Sr Care Pharm. 2019;34(10):674–677.
- Bahl JS, Nelson MJ, Taylor M, et al. Biomechanical changes and recovery of gait function after total hip arthroplasty for osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil. 2018;26(7):847–863.
- Saito T, Tanaka S. Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB. Arthritis Res Ther. 2017;19(1):94.
- Galasso O, Panza S, Santoro M, et al. PTEN elevation, autophagy and metabolic reprogramming may be induced in human chondrocytes during steroids or nutrient depletion and osteoarthritis. J Biol Regul Homeost Agents. 2015;29(Suppl 4):1–S14.
- Roman-Blas JA, Jimenez SA. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthr Cartil. 2006;14(9):839–848.
- Mobasheri A. The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep. 2013;15(10):364.
- Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148.
- Yu CX, Sun S. An emerging role for circular RNAs in osteoarthritis. Yonsei Med J. 2018;59(3):349–355.
- Xiao K, Xia Z, Feng B, et al. Circular RNA expression profile of knee condyle in osteoarthritis by illumina HiSeq platform. J Cell Biochem. 2019;120(10):17500–17511.
- Liao JM, Zhou X, Zhang Y, et al. MiR-1246: a new link of the p53 family with cancer and Down syndrome. Cell Cycle. 2012;11(14):2624–2630.
- Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol. 2013;14(7):676–684.
- Redlich K, Smolen JS. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov. 2012;11(3):234–250.
- Santos LCP, de Moraes AN, Saito ME. Effects of intraarticular ropivacaine and morphine on lipopolysaccharide-induced synovitis in horses. Vet Anaesth Analg. 2009;36(3):280–286.
- Liu X, Zhao P, Ge W. Knockdown of circular RNA circZNF652 remits LPS-induced inflammatory damage by regulating miR-181a. Biofactors. 2020;46(6):1031–1040.
- Scotece M, Conde J, Abella V, et al. Oleocanthal inhibits catabolic and inflammatory mediators in LPS-activated human primary osteoarthritis (OA) chondrocytes through MAPKs/NF-κB pathways. Cell Physiol Biochem. 2018;49(6):2414–2426.
- Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471–478.
- Blanco FJ, Guitian RN, VZquez-Martul E, et al. Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum. 1998;41(2):284–289.
- Pérez-García S, Carrión M, Gutiérrez-Cañas I, et al. Profile of matrix-remodeling proteinases in osteoarthritis: impact of fibronectin. Cells. 2019;9(1):40.
- Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci. 2001;114(Pt 13):2375–2382.